课题基金 / 基金详情

Neuroimaging Prodromal Neurodegeneration in Synucleinopathy

Neuroimaging Prodromal Neurodegeneration in Synucleinopathy
神经影像学 突触核蛋白病的前驱神经变性
批准号:
380556
负责人:
Postuma Ronald B
金额:
$67.16万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2018
资助国家:
加拿大
项目状态:
已结题
起止时间:
2018-03-01 至 2023-03-01

项目摘要

项目成果

Postuma Ronald B的其他基金

相似基金

相关文献

中文摘要
翻译
神经退行性疾病,如帕金森病(PD)和路易体痴呆症(DLB)具有较长的前驱期间隔,这意味着症状已经开始,但疾病尚未完全发展。 这一间隔是开发新的预防性药物的关键,
英文摘要
Neurodegenerative diseases like Parkinson's disease (PD) and Dementia with Lewy bodies (DLB) have a long prodromal interval, meaning that symptoms have started but the disease is not yet fully developed. This interval is key to developing new preventativ
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Caffeine as a Therapeutic Agent in Parkinson's disease
Caffeine for Somnolence and Motor Manifestations of Parkinson's disease
Improving Detection and Management of Non-motor Features of Parkinson's disease - Development of a Knowledge Translation Outreach Strategy
海外基金